Ellevest Inc’s Rapid Micro Biosystems RPID Stock Holding History

Ellevest Inc’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10	Closed	–	–	1820
2022 Q2	$0	Buy	+10	New	+$47	﹤0.01%	1643

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Ellevest Inc's RPID Position: Q3 2022 in Review

Ellevest Inc sold out of Rapid Micro Biosystems (RPID) in Q3 2022, closing a stake of 10 shares.

Ellevest Inc first reported a position in RPID in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 53 funds tracked by Wall St. Rank hold RPID as of Q3 2022.

Ellevest Inc reported no remaining Rapid Micro Biosystems position as of Q3 2022 after selling out during the quarter.
Ellevest Inc sold 10 Rapid Micro Biosystems shares in Q3 2022.
Ellevest Inc first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 1 quarter.
Ellevest Inc's Rapid Micro Biosystems position peaked at $0 in Q2 2022.
53 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.